Loading…

Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents

The present work aims to synthesize four series of phenothiazine incorporation Mannich bases. Therefore, 10-methyl-10H-phenothiazine-3-sulfonamide (4) which was subjected to react with some secondary amines and formaldehyde to give the Mannich bases 5a-f, and 6–13. Compound 13 was then subjected to...

Full description

Saved in:
Bibliographic Details
Published in:Heliyon 2024-04, Vol.10 (7), p.e28573-e28573, Article e28573
Main Authors: Abdula, Ahmed M., Qarah, Ahmad Fawzi, Alatawi, Kahdr, Qurban, Jihan, Abualnaja, Matokah M., Katuah, Hanadi A., El-Metwaly, Nashwa M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c515t-4fce289b7af812581b8b41520d22d26faa6a6efde327c38e49b45581887f799c3
container_end_page e28573
container_issue 7
container_start_page e28573
container_title Heliyon
container_volume 10
creator Abdula, Ahmed M.
Qarah, Ahmad Fawzi
Alatawi, Kahdr
Qurban, Jihan
Abualnaja, Matokah M.
Katuah, Hanadi A.
El-Metwaly, Nashwa M.
description The present work aims to synthesize four series of phenothiazine incorporation Mannich bases. Therefore, 10-methyl-10H-phenothiazine-3-sulfonamide (4) which was subjected to react with some secondary amines and formaldehyde to give the Mannich bases 5a-f, and 6–13. Compound 13 was then subjected to react with some secondary amines and formaldehyde to give the corresponding Mannich bases 14a-f. In total, twenty-two new compounds were synthesized and evaluated for in vitro growth inhibition activity against P. aeruginosa, E. coli, and S. aureus. Among the tested compounds, compounds 3, 5a, 5c, 6, 12, 13, 14d, and 14e exhibited good activity with a MIC value (12.5 μg/mL), compounds 5b, 10, 11, 14a, and 14c exhibited strong activity against the growth of S. aureus with a MIC value (6.25 μg/mL), and compound 14b superior against S. aureus with a MIC value (3.125 μg/mL) compared to drug reference ciprofloxacin with MIC value (2 μg/mL). The molecular docking investigation revealed the presence of many derivatives with high binding affinities and distinct interaction patterns with the target protein. Derivatives 14a-e emerged as the most promising possibilities, displaying the greatest binding energies and a varied variety of interaction types, including hydrogen bonding and pi interactions, over different distances, with derivative 14b exhibiting the highest binding energy at S = −8.3093 kcal/mol. These derivatives displayed superior binding affinities and various interaction mechanisms with the target protein, suggesting that they have great promise as lead compounds for future development into therapeutic medicines. •Synthesis of 3-phenothiazinesulfonamide (4).•Study the reaction of compound 4 with secondary amines and formaldehyde•Reaction of phenothiazine sulfonamide 5a with tetrahydrocarbazole and formaldehyde•Reaction of sulfamoyl phenyl phenothiazine sulfonamide 13 with secondary amines and formaldehyde.•Study the antimicrobial efficacy of the newly made compounds.•Some of newly compounds showed promising antimicrobial activity and their molecular docking was investigated.
doi_str_mv 10.1016/j.heliyon.2024.e28573
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_51374e03c9ea4278bd5031ea1ec5f106</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405844024046048</els_id><doaj_id>oai_doaj_org_article_51374e03c9ea4278bd5031ea1ec5f106</doaj_id><sourcerecordid>3033008723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-4fce289b7af812581b8b41520d22d26faa6a6efde327c38e49b45581887f799c3</originalsourceid><addsrcrecordid>eNqFUk1v1DAUjBCIVqU_AeQjh-7iz8Q5IVS-KhW4wNl6cV4SL4kd7GzRIn48XnYp7aknP9kzY894iuI5o2tGWflqsx5wdLvg15xyuUauVSUeFadcUrXSUtLHd-aT4jylDaWUKV3WlXhanIiMZ6qWp8Xvt5hc7y9I2vllyHO6IOBbMoUR7XaESNpgvzvfk9ARjz_JPKAPy-Dgl_NInLchziHCgi35vPoE3js7kAYSJgKJzDFMLu3p4Bc3ORtD42Ak0KNf0rPiSQdjwvPjelZ8e__u6-XH1fWXD1eXb65XVjG1rGRns8O6qaDTjCvNGt1IpjhtOW952QGUUGLXouCVFRpl3UiVYVpXXVXXVpwVVwfdNsDGzNFNEHcmgDN_N0LsDcTF2RGNYqKSSIWtESSvdNMqKhgCQ6s6Rsus9fqgNW-bCVubfUQY74neP_FuMH24MYzWWlOpssLLo0IMP7aYFpMjsjiO4DFskxFMCc1LpcXDUCoEpbrie6g6QHPEKUXsbp_EqNmXxmzMsTRmXxpzKE3mvbjr55b1ryL_DWP-oRuH0STr0FtsXUS75AjdA1f8AYeM2DE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3033008723</pqid></control><display><type>article</type><title>Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents</title><source>ScienceDirect Journals</source><source>PubMed</source><creator>Abdula, Ahmed M. ; Qarah, Ahmad Fawzi ; Alatawi, Kahdr ; Qurban, Jihan ; Abualnaja, Matokah M. ; Katuah, Hanadi A. ; El-Metwaly, Nashwa M.</creator><creatorcontrib>Abdula, Ahmed M. ; Qarah, Ahmad Fawzi ; Alatawi, Kahdr ; Qurban, Jihan ; Abualnaja, Matokah M. ; Katuah, Hanadi A. ; El-Metwaly, Nashwa M.</creatorcontrib><description>The present work aims to synthesize four series of phenothiazine incorporation Mannich bases. Therefore, 10-methyl-10H-phenothiazine-3-sulfonamide (4) which was subjected to react with some secondary amines and formaldehyde to give the Mannich bases 5a-f, and 6–13. Compound 13 was then subjected to react with some secondary amines and formaldehyde to give the corresponding Mannich bases 14a-f. In total, twenty-two new compounds were synthesized and evaluated for in vitro growth inhibition activity against P. aeruginosa, E. coli, and S. aureus. Among the tested compounds, compounds 3, 5a, 5c, 6, 12, 13, 14d, and 14e exhibited good activity with a MIC value (12.5 μg/mL), compounds 5b, 10, 11, 14a, and 14c exhibited strong activity against the growth of S. aureus with a MIC value (6.25 μg/mL), and compound 14b superior against S. aureus with a MIC value (3.125 μg/mL) compared to drug reference ciprofloxacin with MIC value (2 μg/mL). The molecular docking investigation revealed the presence of many derivatives with high binding affinities and distinct interaction patterns with the target protein. Derivatives 14a-e emerged as the most promising possibilities, displaying the greatest binding energies and a varied variety of interaction types, including hydrogen bonding and pi interactions, over different distances, with derivative 14b exhibiting the highest binding energy at S = −8.3093 kcal/mol. These derivatives displayed superior binding affinities and various interaction mechanisms with the target protein, suggesting that they have great promise as lead compounds for future development into therapeutic medicines. •Synthesis of 3-phenothiazinesulfonamide (4).•Study the reaction of compound 4 with secondary amines and formaldehyde•Reaction of phenothiazine sulfonamide 5a with tetrahydrocarbazole and formaldehyde•Reaction of sulfamoyl phenyl phenothiazine sulfonamide 13 with secondary amines and formaldehyde.•Study the antimicrobial efficacy of the newly made compounds.•Some of newly compounds showed promising antimicrobial activity and their molecular docking was investigated.</description><identifier>ISSN: 2405-8440</identifier><identifier>EISSN: 2405-8440</identifier><identifier>DOI: 10.1016/j.heliyon.2024.e28573</identifier><identifier>PMID: 38571594</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antimicrobial agent ; ciprofloxacin ; energy ; Escherichia coli ; formaldehyde ; growth retardation ; hydrogen ; Molecular docking ; N-Mannich bases ; Phenothiazine ; therapeutics</subject><ispartof>Heliyon, 2024-04, Vol.10 (7), p.e28573-e28573, Article e28573</ispartof><rights>2024 The Authors</rights><rights>2024 The Authors. Published by Elsevier Ltd.</rights><rights>2024 The Authors. Published by Elsevier Ltd. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c515t-4fce289b7af812581b8b41520d22d26faa6a6efde327c38e49b45581887f799c3</cites><orcidid>0000-0002-0619-6206</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988045/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2405844024046048$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3547,27922,27923,45778,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38571594$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdula, Ahmed M.</creatorcontrib><creatorcontrib>Qarah, Ahmad Fawzi</creatorcontrib><creatorcontrib>Alatawi, Kahdr</creatorcontrib><creatorcontrib>Qurban, Jihan</creatorcontrib><creatorcontrib>Abualnaja, Matokah M.</creatorcontrib><creatorcontrib>Katuah, Hanadi A.</creatorcontrib><creatorcontrib>El-Metwaly, Nashwa M.</creatorcontrib><title>Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents</title><title>Heliyon</title><addtitle>Heliyon</addtitle><description>The present work aims to synthesize four series of phenothiazine incorporation Mannich bases. Therefore, 10-methyl-10H-phenothiazine-3-sulfonamide (4) which was subjected to react with some secondary amines and formaldehyde to give the Mannich bases 5a-f, and 6–13. Compound 13 was then subjected to react with some secondary amines and formaldehyde to give the corresponding Mannich bases 14a-f. In total, twenty-two new compounds were synthesized and evaluated for in vitro growth inhibition activity against P. aeruginosa, E. coli, and S. aureus. Among the tested compounds, compounds 3, 5a, 5c, 6, 12, 13, 14d, and 14e exhibited good activity with a MIC value (12.5 μg/mL), compounds 5b, 10, 11, 14a, and 14c exhibited strong activity against the growth of S. aureus with a MIC value (6.25 μg/mL), and compound 14b superior against S. aureus with a MIC value (3.125 μg/mL) compared to drug reference ciprofloxacin with MIC value (2 μg/mL). The molecular docking investigation revealed the presence of many derivatives with high binding affinities and distinct interaction patterns with the target protein. Derivatives 14a-e emerged as the most promising possibilities, displaying the greatest binding energies and a varied variety of interaction types, including hydrogen bonding and pi interactions, over different distances, with derivative 14b exhibiting the highest binding energy at S = −8.3093 kcal/mol. These derivatives displayed superior binding affinities and various interaction mechanisms with the target protein, suggesting that they have great promise as lead compounds for future development into therapeutic medicines. •Synthesis of 3-phenothiazinesulfonamide (4).•Study the reaction of compound 4 with secondary amines and formaldehyde•Reaction of phenothiazine sulfonamide 5a with tetrahydrocarbazole and formaldehyde•Reaction of sulfamoyl phenyl phenothiazine sulfonamide 13 with secondary amines and formaldehyde.•Study the antimicrobial efficacy of the newly made compounds.•Some of newly compounds showed promising antimicrobial activity and their molecular docking was investigated.</description><subject>Antimicrobial agent</subject><subject>ciprofloxacin</subject><subject>energy</subject><subject>Escherichia coli</subject><subject>formaldehyde</subject><subject>growth retardation</subject><subject>hydrogen</subject><subject>Molecular docking</subject><subject>N-Mannich bases</subject><subject>Phenothiazine</subject><subject>therapeutics</subject><issn>2405-8440</issn><issn>2405-8440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFUk1v1DAUjBCIVqU_AeQjh-7iz8Q5IVS-KhW4wNl6cV4SL4kd7GzRIn48XnYp7aknP9kzY894iuI5o2tGWflqsx5wdLvg15xyuUauVSUeFadcUrXSUtLHd-aT4jylDaWUKV3WlXhanIiMZ6qWp8Xvt5hc7y9I2vllyHO6IOBbMoUR7XaESNpgvzvfk9ARjz_JPKAPy-Dgl_NInLchziHCgi35vPoE3js7kAYSJgKJzDFMLu3p4Bc3ORtD42Ak0KNf0rPiSQdjwvPjelZ8e__u6-XH1fWXD1eXb65XVjG1rGRns8O6qaDTjCvNGt1IpjhtOW952QGUUGLXouCVFRpl3UiVYVpXXVXXVpwVVwfdNsDGzNFNEHcmgDN_N0LsDcTF2RGNYqKSSIWtESSvdNMqKhgCQ6s6Rsus9fqgNW-bCVubfUQY74neP_FuMH24MYzWWlOpssLLo0IMP7aYFpMjsjiO4DFskxFMCc1LpcXDUCoEpbrie6g6QHPEKUXsbp_EqNmXxmzMsTRmXxpzKE3mvbjr55b1ryL_DWP-oRuH0STr0FtsXUS75AjdA1f8AYeM2DE</recordid><startdate>20240415</startdate><enddate>20240415</enddate><creator>Abdula, Ahmed M.</creator><creator>Qarah, Ahmad Fawzi</creator><creator>Alatawi, Kahdr</creator><creator>Qurban, Jihan</creator><creator>Abualnaja, Matokah M.</creator><creator>Katuah, Hanadi A.</creator><creator>El-Metwaly, Nashwa M.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0619-6206</orcidid></search><sort><creationdate>20240415</creationdate><title>Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents</title><author>Abdula, Ahmed M. ; Qarah, Ahmad Fawzi ; Alatawi, Kahdr ; Qurban, Jihan ; Abualnaja, Matokah M. ; Katuah, Hanadi A. ; El-Metwaly, Nashwa M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-4fce289b7af812581b8b41520d22d26faa6a6efde327c38e49b45581887f799c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antimicrobial agent</topic><topic>ciprofloxacin</topic><topic>energy</topic><topic>Escherichia coli</topic><topic>formaldehyde</topic><topic>growth retardation</topic><topic>hydrogen</topic><topic>Molecular docking</topic><topic>N-Mannich bases</topic><topic>Phenothiazine</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdula, Ahmed M.</creatorcontrib><creatorcontrib>Qarah, Ahmad Fawzi</creatorcontrib><creatorcontrib>Alatawi, Kahdr</creatorcontrib><creatorcontrib>Qurban, Jihan</creatorcontrib><creatorcontrib>Abualnaja, Matokah M.</creatorcontrib><creatorcontrib>Katuah, Hanadi A.</creatorcontrib><creatorcontrib>El-Metwaly, Nashwa M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Heliyon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdula, Ahmed M.</au><au>Qarah, Ahmad Fawzi</au><au>Alatawi, Kahdr</au><au>Qurban, Jihan</au><au>Abualnaja, Matokah M.</au><au>Katuah, Hanadi A.</au><au>El-Metwaly, Nashwa M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents</atitle><jtitle>Heliyon</jtitle><addtitle>Heliyon</addtitle><date>2024-04-15</date><risdate>2024</risdate><volume>10</volume><issue>7</issue><spage>e28573</spage><epage>e28573</epage><pages>e28573-e28573</pages><artnum>e28573</artnum><issn>2405-8440</issn><eissn>2405-8440</eissn><abstract>The present work aims to synthesize four series of phenothiazine incorporation Mannich bases. Therefore, 10-methyl-10H-phenothiazine-3-sulfonamide (4) which was subjected to react with some secondary amines and formaldehyde to give the Mannich bases 5a-f, and 6–13. Compound 13 was then subjected to react with some secondary amines and formaldehyde to give the corresponding Mannich bases 14a-f. In total, twenty-two new compounds were synthesized and evaluated for in vitro growth inhibition activity against P. aeruginosa, E. coli, and S. aureus. Among the tested compounds, compounds 3, 5a, 5c, 6, 12, 13, 14d, and 14e exhibited good activity with a MIC value (12.5 μg/mL), compounds 5b, 10, 11, 14a, and 14c exhibited strong activity against the growth of S. aureus with a MIC value (6.25 μg/mL), and compound 14b superior against S. aureus with a MIC value (3.125 μg/mL) compared to drug reference ciprofloxacin with MIC value (2 μg/mL). The molecular docking investigation revealed the presence of many derivatives with high binding affinities and distinct interaction patterns with the target protein. Derivatives 14a-e emerged as the most promising possibilities, displaying the greatest binding energies and a varied variety of interaction types, including hydrogen bonding and pi interactions, over different distances, with derivative 14b exhibiting the highest binding energy at S = −8.3093 kcal/mol. These derivatives displayed superior binding affinities and various interaction mechanisms with the target protein, suggesting that they have great promise as lead compounds for future development into therapeutic medicines. •Synthesis of 3-phenothiazinesulfonamide (4).•Study the reaction of compound 4 with secondary amines and formaldehyde•Reaction of phenothiazine sulfonamide 5a with tetrahydrocarbazole and formaldehyde•Reaction of sulfamoyl phenyl phenothiazine sulfonamide 13 with secondary amines and formaldehyde.•Study the antimicrobial efficacy of the newly made compounds.•Some of newly compounds showed promising antimicrobial activity and their molecular docking was investigated.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38571594</pmid><doi>10.1016/j.heliyon.2024.e28573</doi><orcidid>https://orcid.org/0000-0002-0619-6206</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2405-8440
ispartof Heliyon, 2024-04, Vol.10 (7), p.e28573-e28573, Article e28573
issn 2405-8440
2405-8440
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_51374e03c9ea4278bd5031ea1ec5f106
source ScienceDirect Journals; PubMed
subjects Antimicrobial agent
ciprofloxacin
energy
Escherichia coli
formaldehyde
growth retardation
hydrogen
Molecular docking
N-Mannich bases
Phenothiazine
therapeutics
title Design, synthesis, and molecular docking of new phenothiazine incorporated N-Mannich bases as promising antimicrobial agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A53%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20synthesis,%20and%20molecular%20docking%20of%20new%20phenothiazine%20incorporated%20N-Mannich%20bases%20as%20promising%20antimicrobial%20agents&rft.jtitle=Heliyon&rft.au=Abdula,%20Ahmed%20M.&rft.date=2024-04-15&rft.volume=10&rft.issue=7&rft.spage=e28573&rft.epage=e28573&rft.pages=e28573-e28573&rft.artnum=e28573&rft.issn=2405-8440&rft.eissn=2405-8440&rft_id=info:doi/10.1016/j.heliyon.2024.e28573&rft_dat=%3Cproquest_doaj_%3E3033008723%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c515t-4fce289b7af812581b8b41520d22d26faa6a6efde327c38e49b45581887f799c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3033008723&rft_id=info:pmid/38571594&rfr_iscdi=true